Search Results for "Cancer Diagnostics"

06:08 EDT 22nd October 2017 | BioPortfolio

Matching Channels

Matching News

How Sienna Cancer Diagnostics are translating telomerase into a cancer biomarker.

Cliff Holloway, CEO to Sienna Cancer Diagnostics, discusses the development and commercialisation of SCE-A7, the first telomerase detection product.

Quest Diagnostics Completes Acquisition of Med Fusion

Quest Diagnostics has announced the completed its acquisition of the laboratory businesses Med Fusion and Clear Point. Operating from a nearly 200,000 square foot facility in Lewisville, Texas, the t...

20172021 Global Cancer Diagnostics Market Overview: Test Volume and Sales Forecasts by Country, Laboratory Universe [Updated: 30032017] Prices from USD $2450

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of lab...

bioAffinity Technologies Raises $4M to Early-Stage Cancer Diagnostics

bioAffinity Technologies, a San Antonio, TX-based company advancing early-stage cancer diagnostics and precision therapeutics has raised more than $4 million in Series A funding. The Series A fund ref...

Accelerating the development of new cancer therapies; Ketil Widerberg, General Manager, Oslo Cancer Cluster

Four out of ten people will be diagnosed with cancer during their life and it is crucial to develop new diagnostics and medication. Oslo Cancer Cluster is an oncology research and industry cluster de...

True Health Diagnostics Showcases Its Commitment to Educating Doctors, Patients About Hereditary Cancer During Breast Cancer Awareness Month

FRISCO, Texas , Oct. 11, 2017 /- True Health, a leader in integrated diagnostics and healthcare services, has amplified its effort during National Breast Cancer Awareness month to educate doctor...

NovellusDx licenses cancer diagnostics technology from the Gene Editing Institute

To support its work in the cancer diagnostics space, NovellusDx licensed a gene editing technology from the Gene Editing Institute, part of Christiana Care Health System’s Helen F. Graham Cancer Cen...

Preora Diagnostics’ Cancer Screening Platform Honored by Two Chicago Organizations

Evanston, Illinois (PRWEB) September 21, 2017 Preora Diagnostics Inc. , a privately held medical technology company developing low-...

Matching PubMed Articles

Chasing bubbles for cancer diagnostics: Cancer researchers are pursuing membrane-bound microbubbles and exosomes as new diagnostic tools.

Development and Testing of an LED-Based Near-Infrared Sensor for Human Kidney Tumor Diagnostics.

Optical spectroscopy is increasingly used for cancer diagnostics. Tumor detection feasibility in human kidney samples using mid- and near-infrared (NIR) spectroscopy, fluorescence spectroscopy, and Ra...

Molecular diagnostics of ALK-positive lung cancer.

ALK translocation is the 3rd most frequent genetic aberration in lung adenocarcinoma, and several inhibitors are now clinically available in first and second line settings. Accordingly, molecular diag...

Glycosylation changes in serum proteins identify patients with pancreatic cancer.

After more than a decade of biomarker discovery using advanced proteomic and genomic approaches, very few biomarkers have been involved in clinical diagnostics. Most candidate biomarkers are focused o...

Shifting paradigm of cancer diagnoses in clinically relevant samples based on miniaturized electrochemical nanobiosensors and microfluidic devices.

Cancer is one of leading causes of death in the world and occurs in more than two hundred types according to the National Cancer Institute. Its early diagnosis has been remained a prime focus amongst ...

Search Whole site using Google

Quick Search
Advertisement Advertisement